Eptifibatide non cyclic impurity

Product Name
Eptifibatide non cyclic impurity
CAS No.
135900-78-6
Chemical Name
Eptifibatide non cyclic impurity
Synonyms
Eptifibatide Impurity 10;Eptifibatide non cyclic impurity;L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-
CBNumber
CB29436006
Molecular Formula
C35H51N11O9S2
Formula Weight
833.98
MOL File
135900-78-6.mol
More
Less

Eptifibatide non cyclic impurity Property

Density 
1.55±0.1 g/cm3(Predicted)
pka
4.20±0.10(Predicted)
More
Less

Hazard and Precautionary Statements (GHS)

Eptifibatide non cyclic impurity Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Eptifibatide non cyclic impurity Suppliers

China 7 India 1 Global 8
Hubei Yangxin Medical Technology Co., Ltd.
Tel
15374522761
Fax
QQ:2853117752
Email
3003392093@yongstandards.com
Country
China
ProdList
10000
Advantage
55
Shenzhen Excellent Biomedical Technology Co., Ltd.
Tel
0755-26050679 18318671572
Email
2850803126@qq.com
Country
China
ProdList
10001
Advantage
58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd
Tel
18162595016; 18162595016
Email
3287908757@qq.com
Country
China
ProdList
9119
Advantage
58
Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd
Tel
020-18102736 18102736234
Email
LK@zlstandards.com
Country
China
ProdList
8206
Advantage
58
Hubei Molcoo Biotechnology Co., Ltd
Tel
17320513646
Email
anna@molcoo.com
Country
China
ProdList
3245
Advantage
58
Moxin Chemicals
Tel
+86-17320513646 +8617320513646
Email
anna@molcoo.com
Country
China
ProdList
10000
Advantage
58
China National Standard Pharmaceutical Corporation Limited
Tel
+8615391658522
Email
overseasales@yongstandards.com
Country
China
ProdList
11922
Advantage
58

135900-78-6, Eptifibatide non cyclic impurityRelated Search:

L-Aspartic acid, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-, (1→3')-disulfide with L-tryptophyl-L-prolyl-L-cysteinamide (9CI) Eptifibatide impurity 3/Deamidated Eptifibatide Impurity/(3R,11S,17S,20S,25aS)-20-((1H-indol-3-yl)Methyl)-17-(carboxymethyl)-11-(4-guanidinobutyl)-1,9,12,15,18,21-hexaoxodocosahydro-1H-pyrrolo[2,1-g][1,2,5,8,11,14,17,20]dithiahexaazacyclotricosine-3-carbo Cyclo(L-Pro-L-Trp-) L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide) N-[2-(Phenylmethyl)phenyl]-2-chloroacetamide Acetamide, 2-methoxy-N-[2-(phenylmethyl)phenyl]- Methanone, (2-aminophenyl)phenyl-, hydrazone, (Z)- L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide (9CI) Benzamide, N-[(6,11-dihydro-5H-dibenz[b,e]azepin-6-yl)methyl]-2-(hydroxymethyl)- 7-Bromo Epinastine 3'-Hydroxyacetophenone 6-Chloromethylmorphanthridine Acetamide, 2-(1-methylethoxy)-N-[2-(phenylmethyl)phenyl]-

  • Eptifibatide non cyclic impurity
  • L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-
  • Eptifibatide Impurity 10
  • 135900-78-6